Tower Research Capital (TRC)’s Eaton Vance Enhance Equity Income Fund II EOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-243
Closed -$5.69K – 5221
2025
Q4
$5.69K Buy
+243
New +$5.63K ﹤0.01% 4103
2020
Q3
– Sell
-1,382
Closed -$24K – 4883
2020
Q2
$24K Buy
+1,382
New +$22.6K ﹤0.01% 3582
2020
Q1
– Sell
-900
Closed -$16K – 3250
2019
Q4
$16K Buy
+900
New +$15.5K ﹤0.01% 2059
2016
Q2
– Sell
-240
Closed -$3K – 4545
2016
Q1
$3K Sell
240
-780
-76% -$9.63K ﹤0.01% 3075
2015
Q4
$14K Buy
+1,020
New +$13.7K ﹤0.01% 1682
2014
Q4
– Sell
-2,300
Closed -$31K – 4169
2014
Q3
$31K Sell
2,300
-1,482
-39% -$20.3K ﹤0.01% 1946
2014
Q2
$51K Buy
+3,782
New +$50.1K 0.01% 1280
2014
Q1
– Sell
-18,578
Closed -$241K – 4564
2013
Q4
$241K Buy
18,578
+10,410
+127% +$129K 0.04% 432
2013
Q3
$96K Buy
8,168
+3,399
+71% +$40.1K 0.01% 1335
2013
Q2
$55K Buy
+4,769
New +$54.8K ﹤0.01% 855

Other funds holding EOS

Tower Research Capital (TRC)'s EOS Position: Q1 2026 in Review

Tower Research Capital (TRC) sold out of Eaton Vance Enhance Equity Income Fund II (EOS) in Q1 2026, closing a stake of 243 shares — an estimated $5.69K sold.

Tower Research Capital (TRC) first reported a position in EOS in Q2 2013 and held it in 10 quarters. The position peaked at $241K in Q4 2013. 125 funds tracked by Wall St. Rank hold EOS as of Q1 2026.

  • Tower Research Capital (TRC) reported no remaining Eaton Vance Enhance Equity Income Fund II position as of Q1 2026 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 243 Eaton Vance Enhance Equity Income Fund II shares in Q1 2026, an estimated $5.69K.
  • Tower Research Capital (TRC) first reported a position in Eaton Vance Enhance Equity Income Fund II in Q2 2013 and held it in 10 quarters.
  • Tower Research Capital (TRC)'s Eaton Vance Enhance Equity Income Fund II position peaked at $241K in Q4 2013.
  • 125 funds tracked by Wall St. Rank held Eaton Vance Enhance Equity Income Fund II as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.